Spectral Medical (OTCMKTS:EDTXF) Releases Quarterly Earnings Results

Spectral Medical (OTCMKTS:EDTXF) posted its quarterly earnings results on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, Zacks reports.

Spectral Medical Stock Up 1.6 %

EDTXF opened at $0.62 on Friday. Spectral Medical has a twelve month low of $0.32 and a twelve month high of $0.62. The company has a 50-day simple moving average of $0.53 and a 200 day simple moving average of $0.44. The stock has a market capitalization of $176.77 million, a price-to-earnings ratio of -8.86 and a beta of 0.20.

About Spectral Medical

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.